GRM5 and fragile X syndrome: For example, pharmacological interventions of the well-studied mGluR5 pathway in FXS have been successful in overcoming certain (learning deficits and propensity toward audiogenic seizures), but not other (circadian and sleep problems), aspects of the disease in fly and rodent models.